CLOSE
Tags Posts tagged with "Stony Brook Medicine"

Stony Brook Medicine

by -
0 956
Photo from Stony Brook University Hospital

For the estimated 1.6 million Americans diagnosed with symptomatic tricuspid valve regurgitation each year, a significant advancement in treatment is now available on Long Island. With the launch of the new Transcatheter Tricuspid Valve Replacement (TTVR) Program at the Stony Brook Heart Institute (SBHI), patients at Stony Brook Medicine have access to groundbreaking, minimally invasive therapies.

The heart has four valves — aortic, mitral, pulmonary and tricuspid — that control the direction of blood flow. In tricuspid regurgitation (TR), the tricuspid valve’s flaps do not close tightly, allowing blood to leak backward in the heart. Mild cases may cause no symptoms, but others suffer from fatigue, pulsing neck veins, fluid buildup in the abdomen and legs, and irregular, sometimes dangerous, heartbeats. If left untreated, individuals with severe TR can experience heart failure, blood clots, stroke and other organ damage.

In the hands of Stony Brook’s tricuspid valve specialists, the FDA-approved TriClip™ device offers a revolutionary treatment option. Performed under general anesthesia and guided by advanced imaging, the procedure involves placing a catheter through a vein to the heart, where the TriClip™ is precisely placed to bring valve flaps together, reducing backward blood flow. Because the procedure is minimally invasive and avoids open-heart surgery, most patients are up and walking within hours, discharged in one to two days, and back to their regular lives in about a week. Clinical trials published in The New England Journal of Medicine demonstrated that TriClip ™ placement resulted in 87% of patients experiencing a significant reduction in tricuspid regurgitation, compared to less than 5% with medication use alone.

Ahmad Alkhalil, MD, MSc, Director of the Mitral and Tricuspid Interventions at Stony Brook Heart Institute, who performed SBHI’s first TTVR procedure noted, “The tricuspid valve was formerly known as ‘the forgotten valve’ because surgical approaches were too risky and no other treatments were effective for the majority of patients. With our full range of minimally invasive therapies, including tricuspid transcatheter edge-to-edge repair (TEER) and tricuspid transcatheter valve replacement (TTVR), we are proud to be a leader in providing new options for patients on Long Island.”

“We are proud to be at the forefront of bringing new treatment options for symptomatic tricuspid regurgitation,” says Allison McLarty, MD, Interim Chief, Cardiothoracic Surgery, Stony Brook Heart Institute and Professor of Surgery, Renaissance School of Medicine at Stony Brook University. “Our skilled and dedicated physicians are continuously exploring new and innovative approaches to improve outcomes and the patient experience of people with valve disease.”

“Effective treatment begins with a precise diagnosis. Patients at Stony Brook Heart Institute benefit from a full suite of advanced imaging technologies, including 3D transthoracic and transesophageal echocardiography (TTE and TEE), cardiac MRI, CT angiography, nuclear stress testing and carotid ultrasound. These tools allow SBHI’s specialists to map each patient’s unique valve anatomy and tailor treatment to their needs,” added Smadar Kort, MD, Co-Director of the Valve Program and the Director of Non-Invasive Imaging at Stony Brook Heart Institute. “With multiple advanced imaging and procedural locations across Suffolk County, including Stony Brook, Commack and Riverhead, the Heart Institute ensures patients receive top-tier care close to home.”

“At the core of Stony Brook Heart Institute’s TTVR program is a multidisciplinary team of interventional cardiologists, cardiac surgeons, imaging specialists and advance practice practitioners who collaborate closely to ensure every patient receives seamless, compassionate care,” says Hal Skopicki, MD, PhD, Co-Director of Stony Brook Heart Institute and the Ambassador Charles A. Gargano Chair of Cardiology, Renaissance School of Medicine at Stony Brook University. “As an academic medical center actively participating in national and international clinical trials, we provide patients with access to emerging valve devices and interventions not yet widely available — offering many the opportunity to avoid open-heart surgery and benefit from the most cutting-edge, patient-centered cardiovascular care available today.”

To contact the Stony Brook Heart Institute, call 631-44HEART or visit heart.stonybrookmedicine.edu. 

About Stony Brook Heart Institute:  

Stony Brook Heart Institute is located within Stony Brook University Hospital as part of Long Island’s premier university-based medical center. The Heart Institute offers a comprehensive, multidisciplinary program for the prevention, diagnosis and treatment of cardiovascular disease. The staff includes full-time and community-based, board-certified cardiologists and cardiothoracic surgeons, as well as specially trained anesthesiologists, nurses, advanced practice practitioners, respiratory therapists, surgical technologists, perfusionists, and other support staff. Their combined expertise provides state-of-the-art interventional and surgical capabilities in 24-hour cardiac catheterization labs and surgical suites. And while the Heart Institute clinical staff offers the latest advances in medicine, its physician-scientists are also actively enhancing knowledge of the heart and blood vessels through basic biomedical studies and clinical research.

by -
0 949
Summer Swap series at The Jazz Loft in Stony Brook returns on June 3.

The Jazz Loft, 275 Christian Avenue in Stony Brook Village, in partnership with Stony Brook University, Stony Brook Medicine and community businesses, will be presenting the 2025 Summer Stage With A Purpose (Summer SWAP), on a series of Tuesday evenings throughout the summer. The events are FREE to the community.

Summer SWAP will offer visitors a relaxing and scenic outdoor venue on the front lawn of The Jazz Loft to listen to an impressive lineup of performers.

“This series was born from the desire to have the Jazz Loft collaborate with Stony Brook University, and Stony Book Medicine as a way to invest in the community and especially to nurture cultural development,” said The Jazz Loft founder Tom Manuel.

“This summer concert series was born from the desire to give back to our community, to offer high quality performances to everyone without charge, and also to expand our collaborative projects with Stony Brook University, and Stony Book Medicine,” said Manuel. “Summer SWAP is the perfect way to invest in our community and an especially real and genuine way to nurture cultural development. It’s exciting to see how this collaborative concert series has become such a special part of our community tradition.”

“We’re proud to sponsor Summer SWAP and to continue our partnership with The Jazz Loft,” said Heather Banoub, Assistant Vice President of University and Medicine Community Relations. “Bringing people together through music and culture reflects our commitment to enriching the lives of those in our community.”

The Jazz Loft will be offering a variety of refreshments for sale in the Basie Garden which is adjacent to The Jazz Loft. Attendees are welcome to bring their own chairs and blankets to set up on the lawn.

The series performers will include:

Tuesday, June 3 — Jason Marshall Organ Trio

Tuesday, June 17 — Birsa Chatterjee Quartet

Tuesday, July 1 — Kevin Blanca Big Band

Tuesday, July 22 — Dal Segno Trio w/Tom Manuel & Georgia Heers

All performances are from 6 to 8 p.m.

For more information contact the Jazz Loft at: 631-751-1895 or visit https://www.thejazzloft.org

  

by -
0 700
1 of 4
Long Island native and RSOM graduate Kevin Langbart, center, is among the new MDs who will stay at Stony Brook Medicine for their residencies. Photo by Kristy Leibowitz
A group of new MDs from the RSOM celebrate with each other during the school’s 51st Convocation. Photo by Kristy Leibowitz
A total of 133 graduates of the Renaissance School of Medicine (RSOM) recite the Physicians’ Oath for the first time as newly minted MDs. Photo by Kristy Leibowitz
The RSOM Class of 2025 pose and wave during the Convocation on May 19 at Stony Brook University. Photo by Kristy Leibowitz

133 RSOM graduates celebrate during the school’s 51st Convocation; residency training begins in July

The Renaissance School of Medicine (RSOM) at Stony Brook University celebrated its 51st Convocation on May 19 when 133 graduates received their Doctor of Medicine (MD) degree. The newly minted physicians will start their residency training in early July.

A talented and diverse group set to practice medicine in more than 20 specialties – such as residencies related to primary care, anesthesiology, emergency medicine, neurology, radiology, surgery and psychiatry – the RSOM graduates, collectively, will practice at leading hospitals and academic medical centers in New York State and 17 other states. A majority (55 percent) will remain in New York, with nearly 15 percent staying at Stony Brook Medicine.

The need for more physicians in the United States and globally remains high, particularly because of aging populations and the need for physician specialists. With ever increasing new technologies to diagnose and treat diseases, and the emergence of AI and telemedicine, opportunities to further advance Medicine in this 21st Century will expand. New MDs entering the workforce will be a major part of that advancement.

Peter Igarashi, MD, the Knapp Dean of the RSOM and Presider over the Convocation, congratulated the 133 graduates and cited their dedication, perseverance, and achievements during this celebration of their journeys that brought them all to this moment as new physicians.

“Over the last four plus years at the Renaissance School of Medicine, you have received the best medical education that New York State has to offer,” said Dr. Igarashi. “The combination of training in the science and art of medicine and the social determinants of health has prepared you to be doctors, well-equipped for whoever walks in the door.”

Susan M. Wolf, JD, a nationally recognized leader in medicine, law, and ethics, Chair of the Consortium on Law and Values in Health, Environment & the Life Sciences, Regents Professor, and Professor of Medicine at the University of Minnesota, delivered the Convocation Address.

Professor Wolf has devoted her academic career to solving ethical and legal challenges in patient care and biomedical research. Her pioneering work has influenced how medicine approaches end-of-life care, the return of research results and incidental findings, and the ethical integration of technologies like genomics and AI.

She encouraged the students to practice medicine with the highest ethics and to be patient advocates during the caregiving process, helping to empower patients and their decisions in an age when medicine is advancing at a rapid pace even as quality of life and death issues remain paramount.

The 133 new MDs celebrated with each other, RSOM faculty, friends and family members throughout the day. This included a special shout out and a rousing applause from them during the ceremony directed to their parents and loved ones, who sacrificed much time and means throughout the graduates’ medical school journey.

The RSOM Class of 2025 join a long history of the school’s graduates. Since the first graduating class of 1974, the RSOM has issued more than 5,000 MD degrees, more than 600 PhD degrees, and nearly 750 master’s degrees to more than 6,200 graduates.

 

 

by -
0 878
Susan Lane, MD, MACP. Jeanne Neville, Stony Brook Medicine

The program is dedicated to preparing women for senior leadership roles in academic medicine

Susan Lane, MD, MACP, SUNY Distinguished Service Professor and Professor of Medicine in the Renaissance School of Medicine (RSOM) at Stony Brook University, has been named to the 2025-26 Class of Fellows for the Hedwig van Amerigen Executive Leadership in Academic Medicine (ELAM) program. An initiative at Drexel University College of Medicine, the program is dedicated to preparing women for senior leadership roles in schools of medicine, dentistry, public health and pharmacy.

According to Drexel, the ELAM program is specially developed for senior women faculty at the associate or full professorship level who demonstrate the greatest potential for assuming executive leadership positions at academic health centers within the next five years. To be accepted into the program, each fellow much be nominated and supported by the dean or another senior official at their institution. Dr. Lane received multiple senior level nominations and support.

ELAM centers on developing both the professional and personal skills for women to lead and manage in a complex healthcare environment, with a particular focus on the unique challenges of women in leadership positions.

“I am honored to be selected to this 2025-26 Class of ELAM Fellows, and during my career at Stony Brook Medicine I have endeavored to support women in their individual academic journeys and pave the way for them to serve in educational leadership positions,” says Dr. Lane, also Vice Chair of Education in the Department of Medicine and Associate Dean for Clinical Faculty Development for the RSOM.

Work for the incoming class of ELAM fellows begins in June 2025 with online assignments and community-building activities. Each fellow will be expected to develop an Institutional Action Project. A symposium in 2026 will feature the various projects completed from around the nation.

A resident of East Setauket, Dr. Lane, a RSOM faculty member since 2000, says she hopes to create a longitudinal development program for junior faculty at Stony Brook Medicine during their pivotal transition from the role of trainee to faculty member, with the goal to help them thrive as they juggle professional and personal responsibilities.

The effectiveness of ELAM’s distinctive approach to leadership preparation is broadly recognized within the academic health community. ELAM alumnae number more than 1,600 and serve in leadership positions at some 300 academic health centers worldwide.

Tara Huston, MD, Professor of Surgery and Dermatology in the RSOM’s Department of Surgery, is a current ELAM fellow.

For more about the ELAM and its curriculum, see this link.

 

 

 

by -
0 862
METRO photo

By Daniel Dunaief

In the typical process of developing cures for medical problems or diseases, researchers explore the processes and causes and then spend years searching for remedies.

Ke Jian Liu. Photo by Jeanne Neville, Stony Brook Medicine

Sometimes, however, the time frame for finding a solution is cut much shorter, particularly when the Food and Drug Administration has already approved a drug treatment for another problem.

This could be the case for hemorrhagic stroke. Caused by a burst blood vessel that leads to bleeding in the brain, hemorrhagic stroke represents 13 percent of stroke cases, but accounts for 50 percent of stroke fatalities.

That’s because no current treatment exists to stop a process that can lead to cognitive dysfunction or death.

A researcher with a background in cancer and stroke, Ke Jian “Jim” Liu, Professor of Pathology and Associate Director or Basic Science at the Stony Brook Cancer Center who joined Stony Brook University in 2022, has found a mechanism that could make a hemorrhagic stroke so damaging.

When a blood vessel in the brain bursts, protoporphyrin, a compound that attaches to iron to form the oxygen carrying heme in the blood, partners up with zinc, a similar metal that’s in the brain and is released from neurons during a stroke. This combination, appropriately called zinc protoporphyrin, or ZnPP, doesn’t do much under normal conditions, but could be “highly toxic” in hypoxic, or low-oxygen conditions.

“We have done some preliminary studies using cellular and animal stroke models,” said Liu. “We have demonstrated on a small scale” that their hypothesis about the impact of ZnPP and the potential use of an inhibitor for the enzyme that creates it ‘is true.’”

These scientists recently received a $2.6 million grant over five years from National Institute of Neurological Disorders and Stroke, which is a branch of the National Institutes of Health.

Focusing on a key enzyme

After Liu and his colleagues hypothesized that the ZnPP was toxic in a low-oxygen environment, they honed in on ways to reduce its production. Specifically, they targeted ferrochelatase, the enzyme that typically brings iron and protoporphyrin together.

Iron isn’t as available in this compromised condition because it has a positive charge of three, instead of the usual plus two.

Liu discovered the role of zinc in research he published several years ago.

When a hemorrhagic stroke occurs, it creates a “perfect storm,” as the enzyme favors creating a toxic chemical instead of its usual oxygen carrying heme, Liu said. He is still exploring what makes ZnPP toxic.

The group, which includes former colleagues of Liu’s from the University of New Mexico, will continue to explore whether ZnPP and the enzyme ferrochelatase becomes an effective treatment target.

Liu was particularly pleased that currently approved treatments for cancer could be repurposed to protect brain cells during a hemorrhagic stroke. Indeed, with over 80 approved protein kinase inhibitors, which could work to stop the formation of ZnPP during a stroke, Liu and his colleagues have plenty of potential treatment options.

“We’re in a unique position that a clinically available drug that’s FDA approved for cancer treatment” could become a therapeutic solution for a potentially fatal stroke, Liu said.

To be sure, Liu and his colleagues plan to continue to conduct research to confirm that this process works as they suggest and that this possible therapy is also effective.

As with other scientific studies of medical conditions, promising results with animal models or in a lab require further studies and validation before a doctor can offer it to patients.

“This is an animal model, based on a few observations,” said Liu. “Everything needs to be done statistically.”

At this point, Liu is encouraged by these preliminary studies as the subjects that received an inhibitor are “running around,” he said. “You can see the difference with your own eyes. We’re excited to see that.”

Earlier hypotheses for what caused damage during hemorrhagic stroke focused on the release of iron. In research studies, however, using a chelator to bind to iron ions has produced some benefits, but they are small compared to the damage from the stroke. The chelator is “not really making any major difference,” said Liu.

The Stony Brook researcher did an experiment where he compared ZnPP with the damage from other metabolic products.

“ZnPP is several times more toxic than all the other things combined,” which is what makes them believe that ZnPP might be responsible for the damage, he said.

Proof of principle

For the purpose of the grant, Liu said the scientists were focusing on gathering more concrete evidence to support their theory. The researchers are also testing a few of the protein kinase inhibitors to demonstrate that they work.

In their preliminary studies, they chose several inhibitors based on whether the drug penetrates the blood brain barrier and that have a relatively high affinity for ferrochelatase.

“This opens the door for a new phase of the study,” Liu said. “Can we find the best drug that provides the best outcomes? We are not there yet.”

Removing zinc is not an option, as it is a part of 2 percent of the proteome, Liu said. Taking it out would “screw up the entire biological, physiological system,” he added.

Liu speculates that any future drug treatment would involve a relatively small dose at a specific time, although he recognized that any drug could have side effects.

In an uncertain funding climate in which the government is freezing some grants, Liu hopes that the financial support will continue through the duration of the grant.

“Our hope is that at the end of this grant, we can demonstrate” the mechanism of action for ZnPP and can find a reliable inhibitor, he said. “The next step would be to go to a clinical trial with an FDA-approved drug, and that would be fantastic.”

by -
0 1088
Pixabay photo

By Daniel Dunaief

For many local health care workers, the pandemic transitioned from triggering uneasiness about reports of a respiratory illness coming out of China to a significant threat to area residents.

Dr. Susan Donelan, Photo from Stony Brook Medicine/Jeanne Neville

Health care workers were in an all-out scramble to save lives even as information about the disease, its course and treatment, changed.

Five years after the start of a world-altering pandemic, infectious disease experts and emergency medicine specialists shared a range of thoughts about their initial reactions and concerns about this illness as well as insights about lessons learned and readiness to manage through future significant health threats.

Dr. Susan Donelan, Medical Director of Healthcare Epidemiology at Stony Brook Medicine, remembers raising questions about this virus towards late December of 2019. People urged her to go home and have a nice Christmas.

When Hospital CEO Carol Gomes called her on a Sunday and told Donelan she had an hour to get back to her, she recognized the approaching storm.

“I remember saying, ‘It’s a Sunday and she needs me in an hour,’” Donelan recalled. “We’re in it.”

Indeed, over the following months and, as it turned out, years, doctors dealt with numerous unknowns amid a fluid situation that threatened the population and, in particular those who were immunocompromised, had diabetes or respiratory or cardiac issues.

“People forget how bad things were,” said Dr. Gregson Pigott, Commissioner of the Suffolk County Department of Health Services. “So many people were dying” that hospitals needed to figure out where to put the deceased.

Residents also lined up to get the scarce tests for the presence of the virus and often waited days or longer for a result.

Fluid situation

Health care professionals were reacting to a fluid situation in which best practices in terms of treatment and prevention changed even as the virus was mutating.

“It seems like a blur, going back and thinking about those moments,” said Dr. Jennifer Goebel, emergency room doctor at Huntington Hospital. “It was very surreal, taking care of a disease process you knew nothing about and attempting to be the expert when we were still learning.”

Federal, state and county health officials were unsure of the best guidance for a range of safety measures, including the use of masks.

Additionally, health care experts struggled with the level of contagion based on different environments.

“I don’t think anyone really knew about the continuum that could occur depending on the ambient circumstances,” said Donelan. “I think we probably could have done a better job of letting the public know that our communications would evolve as our knowledge evolved.”

Sharing safety messages

During the worst of the pandemic, health care professionals struggled to share messages that would help people make informed decisions about protecting themselves, their families and their communities.

Dr. Sharon Nachman. Photo frm SBU

“Trust in public health was completely undermined,” said Dr. Sharon Nachman, Chief of the Division of Pediatric Infectious Diseases at Stony Brook Children’s Hospital “That hurt all of us.”

Nachman also listened to health care professionals on national TV who were discussing the health crisis. These pundits were sharing information that included far too many inaccessible words and concepts.

“Smart professionals were talking” but people weren’t understanding them, she said.

Additionally, the echo chamber of social media distorted messages, often questioning the developing science and best practices, suggesting conspiracy theories as well as treatments that were either unproven or ineffective.

Having local professionals from area hospitals made a difference on Long Island, Nachman said.

Whenever Nachman went to ShopRite, people who knew she was a part of their community saw her and asked questions.

“When it’s someone local from Northwell, Stony Brook, NYU Winthrop or others, [local communication] really works better,” she said.

Goebel added that she continues to share her medical knowledge not only with patients, but also with family members who have come to the hospital to provide support.

Hospitals, for their part, learned their lesson about stocking personal protective equipment.

“People have learned their lessons” at hospitals, said Pigott. “We need a more adequate stock of PPE.”

Health care provider PTSD

During the worst of the pandemic, one in five doctors who responded to an American Medical Association poll in 2022 said it was likely they would leave their practice within two years.

Dr. Jennifer Goebel. File photo from Northwell Health

“It was so staggering to hear some of these numbers,” said Goebel. Doctors go through over a decade of training. Seeing so many people leave was difficult.

Health care workers struggled, and continue to struggle, with memories and experiences in the midst of a crisis that killed millions around the world.

“I remember going to room nine, intubating a patient and being called to bed 12 and intubating another patient, within a matter of minutes,” said Goebel. 

As the director of wellness in the Emergency Medicine Service Line, Goebel has created new initiatives to help reduce burnout and provide support.

She developed a peer to peer pilot program that started in September in which new physicians, physician’s assistants and nurse practitioners were matched with a more experienced professional from day one.

The effort is designed to help new staff navigate the health system and address any questions or concerns.

“We’re looking to put these processes in place” throughout Northwell, Goebel said. 

Remote medicine

While remote medical choices, such as telehealth, predated the pandemic, these options have become increasingly common, particularly for residents who might struggle to get to a medical visit.

“Because people were forced to use it, with practice, they got better at it,” said Pigott.

Many organizations invested more in telehealth, which also reduces the burden on Emergency Departments.

Teleheatlh has its “risks and benefits,” said Goebel, as it can keep patients who might be vulnerable out of an environment where they might otherwise be exposed to other pathogens.

Goebel appreciates the importance of a visit with a doctor, who can differentiate between an ear ache and a potential indication of shingles.

Fortunately, for many people, Covid has become a much more manageable infection.

Pigott contracted Covid in September. He took Paxlovid, which helped knock out the symptoms within three days.

Pigott is also grateful for vaccines, which provided a dramatic reduction in mortality during the worst of the pandemic, particularly for people who are over 65.

The vaccine was “saving lives,” said Pigott. “There was real evidence that these are doing their jobs and are working out.”

by -
0 483
Clare Whitney, Assistant Professor of Nursing. Photo by Jeanne Neville, Stony Brook Medicine

Clare Whitney, PhD, MBE, RN, Assistant Professor in the Stony Brook University School of Nursing, has been selected as a 2025 Macy Faculty Scholar, a national program that identifies and develops early-career nursing and medicine educators to become more effective leaders.

Dr. Whitney is Stony Brook’s first Macy Faculty Scholar, and she is one of five educators nationwide to make up this distinguished class of 2025. Macy Scholars develop a project and have access to professional development programs, formal mentoring, and educational opportunities. The program begins on July 1.

Dr. Whitney’s Macy Faculty Scholars project is centered around the Alda Healthcare Experience for Nursing (AHE-N), an interprofessional communication skills training designed for nurses. She will work to develop, implement, and evaluate the AHE-N, which aims to advance sustainable solutions for burnout prevention while enhancing interprofessional collaboration for student nurses.

Her nursing research at Stony Brook is focused on reducing burnout and improving the well-being of healthcare professionals. She established an interdisciplinary research program that addresses pressing relational and ethical issues for the healthcare workforce.

“This is an exciting honor and a meaningful recognition of my passion for advancing nursing education,” says Dr. Whitney. “As I continue to grow in my career, this will allow me to collaborate with and receive mentorship from other educators and leaders, strengthening my ability to educate the next generation of nurses and hopefully make a lasting difference in the profession.”

“We are proud to have Dr. Whitney selected as a Macy Faculty Scholar,” says School of Nursing Dean Patricia Bruckenthal. “Given her expertise in bioethics and health communication science, she will no doubt make an impact on promoting collaboration among health professionals and preparing future nurse leaders to deliver ethical patient-centered care in our complex healthcare environment.”

At Stony Brook, Dr. Whitney is also an affiliated faculty member in the Center for Medical Humanities, Compassionate Care, and Bioethics in the Renaissance School of Medicine.

“As an early career faculty member, Dr. Whitney has an impressive body of scholarship related to addressing relational and ethical issues among health professionals,” adds Dr. Holly J. Humphrey, President of the Josiah Macy Jr. Foundation, the organization that sponsors the program.

 

 

by -
0 779
Stony Brook Medicine participates in the American Heart Association's "Go Red for Women" campaign to raise awareness about cardiovascular disease.(2/7/25)

On Friday, February 7,  National Wear Red Day®, staff from Stony Brook University Hospital wore red to help raise awareness of women’s No. 1 killer – cardiovascular disease. The annual #WearRedDay during American Heart Month honors those we have lost to heart disease and aims to raise awareness of the actions we can all take to prevent it.

by -
0 692
Photo courtesy of Stony Brook Medicine

Stony Brook Medicine (SBM) has received the highest level of achievement from Healthgrades, as one of America’s 50 Best for 2025. This achievement places Stony Brook Medicine among the top 1% nationwide for overall care excellence. Stony Brook University Hospital, Stony Brook Southampton Hospital, and Stony Brook Eastern Long Island Hospital are collectively assessed by Healthgrades and share the America’s 50 Best Hospitals Award™.

“This distinction reflects our shared commitment across Stony Brook Medicine to bring exceptional care to our patients,” says William A. Wertheim, MD, MBA, Executive Vice President, Stony Brook Medicine. “This is only possible when we collectively maintain the highest standards of quality throughout the organization.”

“I am grateful to all of our healthcare professionals for their dedication to excellence,” says Carol A. Gomes, MS, FACHE, CPHQ, Chief Executive Officer, Stony Brook University Hospital. “Our steady increase in rankings — from the top 250 since 2015, to the top 100 since 2019, and now the top 50 for three years in a row — can give patients the confidence in knowing that Stony Brook delivers consistent, high-quality care.”

To determine the top hospitals for 2025, Healthgrades evaluated risk-adjusted mortality and complication rates for more than 30 conditions and procedures at approximately 4,500 hospitals nationwide. Healthgrades’ annual analysis revealed significant performance gaps between the nation’s highest- and lowest-achieving hospitals, making it increasingly important to seek care at a top-rated facility. From 2021-2023, if all hospitals, as a group, performed similarly to America’s 50 Best, 173,516 lives could potentially have been saved.*

“As one of America’s 50 Best, Stony Brook Medicine is elevating the standard for quality care nationwide,” says Brad Bowman, MD, Chief Medical Officer and Head of Data Science at Healthgrades. “Healthgrades commends Stony Brook Medicine for their leadership and ongoing commitment to providing the best possible care for all patients on Long Island.”

The Best Hospitals Award comes on the heels of receiving numerous specialty awards this past fall, underscoring Stony Brook‘s dedication to exceptional patient care. These include:

  • The only in New York State to be recognized as one of America’s 100 Best Hospitals for Stroke Care for 10 years in a row (2016-2025)
  • Five-Star Recipient for Treatment of Heart Attack (2022-25)
  • Five-Star Recipient for Treatment of Heart Failure (2014-25)
  • Five-Star Recipient for Cranial Neurosurgery (2020-2025)
  • Five-Star Recipient for Treatment of Stroke (2015-2025)
  • Neurosciences Excellence Award™ (2016-2025)
  • Cranial Neurosurgery Excellence Award™ (2020-2025)
  • Stroke Care Excellence Award™ (2016-2025)
  • Five-Star Recipient for Treatment of Chronic Obstructive Pulmonary Disease (2025)
  • Five-Star Recipient for Treatment of GI Bleed (2024-2025)
  • Five-Star Recipient for Treatment of Sepsis (2015-2025)
  • Five-Star Recipient for Treatment of Respiratory Failure (2021-2025)
  • Outpatient Orthopedic Surgery Excellence Award™ (2025)
  • Five-Star Recipient for Outpatient Prostate Care Excellence (2025)
  • Outpatient Prostate Care Excellence Award™(2025)

As care variation grows, consumers can find and select a top-rated hospital to maximize their outcome. Consumers can visit healthgrades.com for guidance on how to find best-in-class care in 2025, with additional resources on how Healthgrades rates hospitals and why hospital quality matters available here.

*Statistics are based on Healthgrades analysis of MedPAR data for years 2021 through 2023 and represent three-year estimates for Medicare patients only. Click here to view the complete 2025 America’s Best Hospital Awards Methodology.

About Stony Brook Medicine:

Stony Brook Medicine integrates and elevates all of Stony Brook University’s health-related initiatives: education, research and patient care. It includes five Health Sciences schools — Renaissance School of Medicine, School of Dental Medicine, School of Health Professions, School of Nursing and School of Social Welfare — as well as Stony Brook University Hospital, Stony Brook Southampton Hospital, Stony Brook Eastern Long Island Hospital, StonyBrook Children’s Hospital and more than 200 community-based healthcare settings throughout Suffolk County. To learn more, visitwww.stonybrookmedicine.edu.

About Healthgrades:

Healthgrades is dedicated to empowering meaningful connections between patients, doctors, and hospitals. As the #1 platform for finding a doctor and a leader in healthcare transparency, we help millions of consumers each month find and schedule appointments with their healthcare professional of choice and prepare for their appointments with best-in-class, treatment-focused content.

by -
0 677
METRO photo

Stony Brook Medicine (SBM) is partnering with the Suffolk Academy of Medicine to host a Galentine’s Women’s Health Fair aimed at empowering women in Suffolk County with valuable health resources and information. The free, community-focused event will take place on Wednesday, February 12 from 6:30 p.m. to 9:30 p.m. at the Long Island Aquarium, 431 East Main Street in Riverhead.

“Stony Brook Medicine is proud to support the well-being of women in our community and provide them with the resources they need to thrive,” says Carol Gomes, chief executive officer of Stony Brook University Hospital. “Initiatives like this —whether aimed at prevention, education, or care—strengthen the foundation of healthier families and a healthier future.”

“We are thrilled to bring this resource to the women of our community,” said Nicole Gerberg, Executive Director of Suffolk Academy of Medicine. “Women play a pivotal role in shaping healthy families and communities, and this event is a way to give back and support their well-being.”

The fair is open to all Suffolk County residents, 16 years and older and will feature:

  • Educational wellness demonstrations
  • Talks with Stony Brook Medicine health professionals, as well as other medical institutions, including experts in breast cancer, breast imaging, radiology, massage therapy, nutrition, exercise physiology and LGBTQ* healthcare services
  • Sweet treats in honor of Valentine’s Day
  • Raffles
  • A cash bar
  • And more!

*To attend the Valentine’s Women’s Health Fair, the public must RSVP. The form can be found at this link.

About Stony Brook Medicine:

Stony Brook Medicine integrates and elevates all of Stony Brook University’s health-related initiatives: education, research and patient care. It includes five Health Sciences schools — Renaissance School of Medicine, School of Dental Medicine, School of Health Professions, School of Nursing and School of Social Welfare — as well as Stony Brook University Hospital, Stony Brook Southampton Hospital, Stony Brook Eastern Long Island Hospital, Stony Brook Children’s Hospital and more than 200 community-based healthcare settings throughout Suffolk County. To learn more, visit www.stonybrookmedicine.edu.

About Suffolk Academy of Medicine:

The Suffolk Academy of Medicine is dedicated to promoting the health and wellness of Suffolk County residents by providing education, resources, and community outreach.

123...12Next Page 1 of 12
TBR News Media is your local news and entertainment website.
We provide you with the latest breaking news and information for your community.
Contact us: [email protected]

Most Viewed

©